Navigation Links
Latest coffee and health research to be debated at the World Congress on Prevention of Diabetes
Date:11/8/2012

Recent scientific evidence has consistently linked regular, moderate coffee consumption with a reduced risk of developing type 2 diabetes. An update of this research will be presented by experts working in this field at the World Congress on Prevention of Diabetes and Its Complications (WCPD), taking place on 11-14 November in Madrid, Spain.

The parallel session "Good things in life: Can coffee help in diabetes prevention?" will take place on Monday, 12 November at 11:30 a.m. It is sponsored by the Institute for Scientific Information on Coffee, a not-for-profit organisation devoted to the study and disclosure of science related to coffee and health.

The panel will be chaired by Dr. Pablo Aschner, Associate Professor of Endocrinology at the Javeriana University School of Medicine and Siamak Bidel, Senior Researcher at the University of Helsinki. Four speakers will present an update of recent research on different aspects of coffee and diabetes, followed by a panel discussion and an open debate.

Professor Jaakko Tuomilehto, Professor of Public Health at the University of Helsinki, will present the latest results from coffee intervention trials, building on existing work showing that drinking 3 to 4 cups of coffee per day is associated with an approximate 25% lower risk of developing type 2 diabetes, compared to consuming none or less than 2 cups per day.

Dr. Pilar Riob Servn, Associate Chief of Endocrinology and Nutrition at the Jimnez Daz-Capio Hospital of Madrid, will discuss the significance of clinical parameters found so far regarding coffee and diabetes.

Dr. Nathan Matusheski, Senior Scientist at Kraft Foods, will be looking at the potential mechanisms that may govern the relationship between coffee and type 2 diabetes, highlighting the potential role of antioxidants in coffee, such as chlorogenic acid and trigonelline.

Professor Edith Feskens, Professor of Nutrition and Epidemiology at the National Institute of Public Health and the Environment in the Netherlands, will end the presentations with an overview of the epidemiological evidence relating to coffee and reduced risk of type 2 diabetes.

Based on the increasing scientific evidence that links regular, moderate coffee consumption with a reduced risk of developing type 2 diabetes, ISIC believed it was relevant to sponsor this session in order to increase awareness amongst experts on diabetes and prevention and help them to educate the public and eradicate misconceptions about coffee and health not based on solid scientific evidence.


'/>"/>
Contact: Emma Knott
emma.knott@kaizo.co.uk
020-317-64715
European Science Foundation
Source:Eurekalert

Related medicine news :

1. Register now! San Diego meeting will showcase latest aging discoveries
2. Dengue Vaccine Initiative welcomes latest progress in vaccine development
3. The latest science and treatments in emergency cardiac care
4. Meeting in Jordan to educate medical professionals on latest advances in osteoporosis
5. UT Southwestern investigators awarded $48.2 million in latest round of CPRIT grants
6. Elinext Leverages Latest QR Code and NFC Technologies in Mobile App Development for Retailers, Manufacturers, Advertisers, and Real Estate Companies
7. SLEEP 2012 presents latest in sleep medicine and research June 11-13 in Boston
8. Heavy Coffee Intake May Affect Fertility Treatments: Study
9. 5 or more cups of coffee a day reduce the chance of IVF success by around 50 percent
10. Coffee May Cut Your Risk for Common Form of Skin Cancer
11. Coffee consumption inversely associated with risk of most common form of skin cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize each ... Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into hand ... select a ProHand generator and drag it above media or text in the Final ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... CHAPEL HILL, N.C. , June 24, 2016 ... in healthcare decisions and regulators/payers have placed more ... this new environment, patient support programs in the ... support for patients, medications. Consequently, pharmaceutical companies are ... to ensure they are providing products and services ...
(Date:6/24/2016)... June 24, 2016  Collagen Matrix, Inc., ("Collagen ... and manufacturing of collagen and mineral based medical ... that Bill Messer has joined the ... further leverage the growing portfolio of oral surgery, ... Bill joins the Collagen Matrix executive team ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
Breaking Medicine Technology: